Available Courses
VIO 2022 - Aortic - Part 1
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
VIO 2022 - Aortic - Part 2
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
VIO 2022 - PAD/ LOWER LIMB - Part 1
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
VIO 2022 - PAD/ LOWER LIMB - Part 2
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
VIO 2022 - Venous - Part 1
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
VIO 2022 - Venous - Part 2
- 2.00
Published:
Learning objectives
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
Most Recent
Medical Options for Advanced HFpEF/HFmrEF Patients: An Expert-Guided Virtual Ward Round
- 1.00
Published:
Learning objectives
- Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
- Select appropriate patients for advanced medical therapy
- Recall recent trial data for novel therapeutic approaches
- Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF
The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM
- 1.00
Published:
Learning objectives
- Recall the most recent epidemiological data on ATTR-CM incidence and diagnostic trends
- List red flags indicating the presence of ATTR amyloidosis
- Identify patients who should undergo detailed diagnosis work-up or referral
- List the advantages of emerging classes of agents being evaluated in ATTR-CM